Smith-Midland Corporation SMID 深 沪
已收盘 10-31 16:00:00 美东时间
36.46
-1.530
-4.03%
华盛通- 最 高38.16
- 今 开38.16
- 成交量 9494股
- 最 低 36.46
- 昨 收 37.99
- 总市值 1.93亿
- 52周最高 51.96
- 市盈率 静 25.13
- 换手率 0.00%
- 52周最低 25.13
- 委 比 2.44%
- 总股本 530.46万
- 历史最高 51.96
- 量 比 0.98
- 振 幅 4.47%
- 历史最低 7.856
- 每 手 1
- 风险率 5.26%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多IDEAYA Biosciences to Participate in Upcoming November 2025 Investor Relations Events
SOUTH SAN FRANCISCO, Calif., Oct. 27, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of target...
10-27 18:00
CleanSpark the latest bitcoin miner to move into AI infrastructure; stock jumps
CleanSpark (NASDAQ:CLSK) shares surged 14% in Monday afternoon trading after the company said it's expanding beyond bitcoin (BTC-USD) mining by developing and operating AI data center infrastructure, ...
10-21 00:17
Google likely to release Gemini 3 model in December: report
Google (NASDAQ:GOOG) (NASDAQ:GOOGL) is likely to release the next version of its artificial intelligence large language model, known as Gemini 3, in December, technology journalist Alex Heath reported...
10-18 03:30
Headwaters Capital falls 2.7% in Q3; adds Driven Brands, exits Bentley Systems
The Headwaters Capital Management, LLC portfolio declined -2.7% during Q3 2025 compared to a +5.3% gain for the Russell Mid Cap Index over the same period. Driven Brands (NASDAQ:DRVN): A new starter p...
10-17 01:05
全球人工智能热潮助力！阿斯麦订单超预期
全球最大芯片制造设备供应商阿斯麦（ASML，股票代码 ASML.AS）于周三重申，预计将从蓬勃发展的人工智能（AI）投资中受益，但同时警告，明年来自中国市场...
10-15 17:05
Allogene licensor Cellectis faces patent lawsuit in the U.S.
Cancer drug developer Allogene Therapeutics (NASDAQ:ALLO) announced on Tuesday that its licensor, Cellectis (NASDAQ:CLLS), is facing a lawsuit in the U.S. over allegations of patent infringement relat...
10-14 22:25
ClearBridge SMID Cap Growth Strategy
The ClearBridge SMID Cap Growth Strategy underperformed its Russell 2500 Growth Index benchmark during the third quarter, with the index gaining 10.7%. As such, the performance of SMID growth equitie...
10-13 23:15
Smith-Midland Bags Over $2M In Contracts Featuring SlenderWall Architectural Precast Cladding System
Smith-Midland Corporation (NASDAQ:SMID), a provider of innovative, high-quality proprietary and patented precast concrete products and systems, announced two major contracts, with a combined value of more than $2
10-09 22:12
Arovella Therapeutics Showcases iNKT Cell Therapy at ASX SMIDcaps Conference
Arovella Therapeutics Limited ( ($AU:ALA) ) has shared an announcement. Arovell...
09-24 07:27
